A Win For ViewRay, Inc.
Mon, Jan 04, 2021 at 05:30 PM
ViewRay, Inc. (VRAY:NASDAQ) rocketted at $6.41, representing a gain of 67.8%. The stock appeared on our News Catalysts scanner on Mon 04 Jan 21 at 09:43 AM in the 'BIOTECH' category. From Thu 17 Dec 20, the stock recorded 11.11% Up Days and 20.00% Green Days
The stock spiked on Wed 09 Dec 20 at $5.19 with a volume of 5M+, and its share price has been moving sideways in recent weeks.
About ViewRay, Inc. (VRAY:NASDAQ)
ViewRay Inc is a medical device company. The company is engaged in designing, manufacturing and marketing MRI guided radiation therapy system that images and treats cancer patients.
Top 10 Gainers:
- Check-Cap Ltd. (CHEK:NASDAQ), 215.22%
- Bionano Genomics, Inc. (BNGO:NASDAQ), 133.77%
- Jaguar Health, Inc. (JAGX:NASDAQ), 118.4%
- TransEnterix, Inc. (TRXC:NYSEMKT), 87.2%
- The9 Limited (NCTY:NASDAQ), 87.01%
- ViewRay, Inc. (VRAY:NASDAQ), 67.8%
- Ocugen, Inc. (OCGN:NASDAQ), 67.76%
- Zomedica Pharmaceuticals Corp. (ZOM:NYSEMKT), 51.78%
- PAND (PAND:NASDAQ), 47.74%
- KSPN (KSPN:NASDAQ), 39.23%